Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.
Saved in:
| Title: | Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024. |
|---|---|
| Authors: | Antunes L; Epiconcept, Paris, France., Rojas-Castro M; Epiconcept, Paris, France., Lozano M; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Martínez-Baz I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain., Leroux-Roels I; Department of Infection Control, Ghent University Hospital, Ghent, Belgium.; Center for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium., Borg ML; Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta., Oroszi B; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Fitzgerald M; Health Service Executive-Health Protection Surveillance Centre (HPSC), Dublin, Ireland., Dürrwald R; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany., Jancoriene L; Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania., Machado A; Epidemiology Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal., Petrović G; Croatian Institute of Public Health, Zagreb, Croatia., Lazar M; Cantacuzino National Military-Medical Institute for Research and Development, Bucharest, Romania., Součková L; University Hospital Brno, Masaryk University, Brno, Czechia., Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden., Howard J; Epiconcept, Paris, France., Verdasca N; Infectious Diseases Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal., Basile L; Sub-Directorate General of Surveillance and Response to Public Health Emergencies, Public Health Agency of Catalonia, Generalitat of Catalonia, Barcelona, Spain., Castilla J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain., Ternest S; Department of Infection Control, Ghent University Hospital, Ghent, Belgium., Džiugytė A; Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta., Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Duffy R; Health Service Executive-Health Protection Surveillance Centre (HPSC), Dublin, Ireland., Hackmann C; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany., Kuliese M; Department of Infectious Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania., Gomez V; Epidemiology Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal., Makarić ZL; Croatian Institute of Public Health, Zagreb, Croatia., Marin A; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania., Husa P; University Hospital Brno, Masaryk University, Brno, Czechia., Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden., Rose AMC; Epiconcept, Paris, France. |
| Corporate Authors: | VEBIS SARI VE network team |
| Source: | Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2025 Mar; Vol. 19 (3), pp. e70081. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic) Linking ISSN: 17502640 NLM ISO Abbreviation: Influenza Other Respir Viruses Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40059069 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Antunes+L%22">Antunes L</searchLink>; Epiconcept, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rojas-Castro+M%22">Rojas-Castro M</searchLink>; Epiconcept, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lozano+M%22">Lozano M</searchLink>; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-Baz+I%22">Martínez-Baz I</searchLink>; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Leroux-Roels+I%22">Leroux-Roels I</searchLink>; Department of Infection Control, Ghent University Hospital, Ghent, Belgium.; Center for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Borg+ML%22">Borg ML</searchLink>; Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta.<br /><searchLink fieldCode="AU" term="%22Oroszi+B%22">Oroszi B</searchLink>; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Fitzgerald+M%22">Fitzgerald M</searchLink>; Health Service Executive-Health Protection Surveillance Centre (HPSC), Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Dürrwald+R%22">Dürrwald R</searchLink>; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Jancoriene+L%22">Jancoriene L</searchLink>; Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.<br /><searchLink fieldCode="AU" term="%22Machado+A%22">Machado A</searchLink>; Epidemiology Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Petrović+G%22">Petrović G</searchLink>; Croatian Institute of Public Health, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Lazar+M%22">Lazar M</searchLink>; Cantacuzino National Military-Medical Institute for Research and Development, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Součková+L%22">Součková L</searchLink>; University Hospital Brno, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Bacci+S%22">Bacci S</searchLink>; European Centre for Disease Prevention and Control, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Howard+J%22">Howard J</searchLink>; Epiconcept, Paris, France.<br /><searchLink fieldCode="AU" term="%22Verdasca+N%22">Verdasca N</searchLink>; Infectious Diseases Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Basile+L%22">Basile L</searchLink>; Sub-Directorate General of Surveillance and Response to Public Health Emergencies, Public Health Agency of Catalonia, Generalitat of Catalonia, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Castilla+J%22">Castilla J</searchLink>; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Ternest+S%22">Ternest S</searchLink>; Department of Infection Control, Ghent University Hospital, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Džiugytė+A%22">Džiugytė A</searchLink>; Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta.<br /><searchLink fieldCode="AU" term="%22Túri+G%22">Túri G</searchLink>; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Duffy+R%22">Duffy R</searchLink>; Health Service Executive-Health Protection Surveillance Centre (HPSC), Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Hackmann+C%22">Hackmann C</searchLink>; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kuliese+M%22">Kuliese M</searchLink>; Department of Infectious Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.<br /><searchLink fieldCode="AU" term="%22Gomez+V%22">Gomez V</searchLink>; Epidemiology Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Makarić+ZL%22">Makarić ZL</searchLink>; Croatian Institute of Public Health, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Marin+A%22">Marin A</searchLink>; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Husa+P%22">Husa P</searchLink>; University Hospital Brno, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Nicolay+N%22">Nicolay N</searchLink>; European Centre for Disease Prevention and Control, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Rose+AMC%22">Rose AMC</searchLink>; Epiconcept, Paris, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22VEBIS+SARI+VE+network+team%22">VEBIS SARI VE network team</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101304007%22">Influenza and other respiratory viruses</searchLink> [Influenza Other Respir Viruses] 2025 Mar; Vol. 19 (3), pp. e70081. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101304007 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1750-2659 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217502640%22">17502640 </searchLink><i>NLM ISO Abbreviation: </i>Influenza Other Respir Viruses <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40059069 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/irv.70081 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70081 Titles: – TitleFull: Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Antunes L – PersonEntity: Name: NameFull: Rojas-Castro M – PersonEntity: Name: NameFull: Lozano M – PersonEntity: Name: NameFull: Martínez-Baz I – PersonEntity: Name: NameFull: Leroux-Roels I – PersonEntity: Name: NameFull: Borg ML – PersonEntity: Name: NameFull: Oroszi B – PersonEntity: Name: NameFull: Fitzgerald M – PersonEntity: Name: NameFull: Dürrwald R – PersonEntity: Name: NameFull: Jancoriene L – PersonEntity: Name: NameFull: Machado A – PersonEntity: Name: NameFull: Petrović G – PersonEntity: Name: NameFull: Lazar M – PersonEntity: Name: NameFull: Součková L – PersonEntity: Name: NameFull: Bacci S – PersonEntity: Name: NameFull: Howard J – PersonEntity: Name: NameFull: Verdasca N – PersonEntity: Name: NameFull: Basile L – PersonEntity: Name: NameFull: Castilla J – PersonEntity: Name: NameFull: Ternest S – PersonEntity: Name: NameFull: Džiugytė A – PersonEntity: Name: NameFull: Túri G – PersonEntity: Name: NameFull: Duffy R – PersonEntity: Name: NameFull: Hackmann C – PersonEntity: Name: NameFull: Kuliese M – PersonEntity: Name: NameFull: Gomez V – PersonEntity: Name: NameFull: Makarić ZL – PersonEntity: Name: NameFull: Marin A – PersonEntity: Name: NameFull: Husa P – PersonEntity: Name: NameFull: Nicolay N – PersonEntity: Name: NameFull: Rose AMC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2025 Mar Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1750-2659 Numbering: – Type: volume Value: 19 – Type: issue Value: 3 Titles: – TitleFull: Influenza and other respiratory viruses Type: main |
| ResultId | 1 |